Divi's Laboratories Ltd.
Snapshot View

2752.30 +1.45 ▲0.1%

08 February 2023, 09:05:59 AM
Volume: 677

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.divislabs.com
Market Cap 72,982.62 Cr.
Enterprise Value(EV) 69,646.00 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 90.30 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 30.45 Trailing Twelve Months Ending 2022-12
Industry PE 32.80 Trailing Twelve Months Ending 2022-12
Book Value / Share 468.66 Trailing Twelve Months Ending 2022-12
Price to Book Value 5.87 Calculated using Price: 2,749.20
Dividend Yield 1.09 Period Ending 2022-03
No. of Shares Subscribed 26.55 Cr. 265,468,580 Shares
FaceValue 2
Company Profile
The Company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.05%
1 Week
-18.01%
1 Month
-19.87%
3 Month
-19.39%
6 Month
-30.10%
1 Year
-35.66%
2 Year
-27.22%
5 Year
+167.24%
10 Year
+434.17%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 28.31 26.37 28.91 21.98 15.55 21.00 19.30 23.90 28.16
Return on Capital Employed (%) 36.04 33.06 35.57 28.75 21.68 28.50 25.36 32.07 35.06
Return on Assets (%) 19.92 18.21 22.49 17.21 11.12 15.78 15.11 19.07 22.77

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 2,963 3,495 4,293 5,357 5,925 6,957 7,310 9,295 11,728 12,135
Non Curr. Liab. 650 842 85 1,412 1,769 991 295 364 437 456
Curr. Liab. 627 776 520 659 653 847 1,821 1,728 2,454 914
Minority Int.
Equity & Liab. 4,241 5,112 4,898 7,429 8,347 8,795 9,425 11,387 14,619 13,505
Non Curr. Assets 1,984 2,340 1,871 3,418 3,812 4,145 3,851 4,596 5,009 5,075
Curr. Assets 2,256 2,772 3,027 4,011 4,535 4,650 5,574 6,791 9,610 8,430
Misc. Exp. not W/O
Total Assets 4,241 5,112 4,898 7,429 8,347 8,795 9,425 11,387 14,619 13,505

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 2,532 3,115 3,776 4,064 3,891 4,946 5,394 6,969 8,960 8,335
Other Income 71 45 97 75 113 156 190 63 116 335
Total Income 2,603 3,160 3,874 4,139 4,005 5,102 5,584 7,032 9,076 8,670
Total Expenditure -1,517 -1,949 -2,358 -2,617 -2,629 -3,073 -3,571 -4,108 -5,079 -5,355
PBIDT 1,086 1,211 1,516 1,522 1,376 2,029 2,013 2,924 3,997 3,316
Interest -3 -3 -5 -3 -2 -5 -7 -2 -2 -1
Depreciation -92 -136 -118 -123 -142 -169 -186 -256 -312 -337
Taxation -218 -221 -267 -335 -354 -502 -443 -682 -723 -581
Exceptional Items
PAT 773 852 1,126 1,060 877 1,353 1,377 1,984 2,960 2,397
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 773 852 1,126 1,060 877 1,353 1,377 1,984 2,960 2,397
Adjusted EPS 29 32 42 40 33 51 52 75 112 90

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 480 557 826 1,038 1,150 776 954 1,216 1,947 1,912
Cash Fr. Inv. -255 -305 -521 -406 -1,140 -478 -685 -83 75 -2,195
Cash Fr. Finan. -231 -249 -303 -631 2 -314 -246 -1,091 -35 -532
Net Change -5 3 3 0 13 -17 23 41 1,987 -816
Cash & Cash Eqvt 12 15 18 18 -4 -21 2 43 2,030 1,215

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 51.95 51.95 51.95 51.95 51.95 51.94 51.94 51.94 51.94
Public 48.05 48.05 48.05 48.05 48.05 48.06 48.06 48.06 48.06
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 03 Feb 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Divi's Laboratories Limited has informed the Exchange about Link of Recording
Fri, 03 Feb 2023
Financial Result Updates
Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022.
Wed, 25 Jan 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Divi's Laboratories Limited has informed the Exchange about Schedule of earnings call for Q3FY23 results

Technical Scans View Details >>

Tue, 07 Feb 2023
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,289.12 1,006.80 +0.0%
Cipla Ltd. 83,244.79 1,028.90 -0.2%
Dr. Reddy's Laboratories Ltd. 73,968.14 4,434.00 -0.1%
Apollo Hospitals Enterprise Ltd. 62,084.06 4,301.40 -0.3%
Torrent Pharmaceuticals Ltd. 51,953.07 1,537.95 +0.1%
Zydus Lifesciences Ltd. 48,525.07 479.00 -0.1%
Abbott India Ltd. 44,533.86 20,920.00 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.29 1,006.80 +0.0%
Cipla Ltd. Consolidated 2022-12 31.56 1,028.90 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.30 4,434.00 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 74.00 4,301.40 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.45 1,537.95 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.54 479.00 -0.1%
Abbott India Ltd. Standalone 2022-09 50.51 20,920.00 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 1,006.80 +0.0%
Cipla Ltd. Consolidated 2022-12 3.67 1,028.90 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.36 4,434.00 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.38 4,301.40 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.14 1,537.95 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.81 479.00 -0.1%
Abbott India Ltd. Standalone 2022-09 16.41 20,920.00 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,006.80 +0.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,028.90 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,434.00 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,301.40 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.95 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 479.00 -0.1%
Abbott India Ltd. Standalone 2022-03 0.00 20,920.00 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.80 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,028.90 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,434.00 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,301.40 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.95 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.00 -0.1%
Abbott India Ltd. Standalone 2022-03 29.95 20,920.00 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.80 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,028.90 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,434.00 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,301.40 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.95 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.00 -0.1%
Abbott India Ltd. Standalone 2022-03 29.95 20,920.00 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,006.80 +0.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,028.90 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,434.00 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,301.40 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.95 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 479.00 -0.1%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,920.00 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,006.80 +0.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,028.90 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,434.00 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,301.40 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.95 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 479.00 -0.1%
Abbott India Ltd. Standalone 2022-03 798.70 20,920.00 -0.3%

FAQ's On Divi's Laboratories Ltd.

What is Divi's Lab share price?

Can I buy Divi's Lab shares now?

What is the Dividend Yield of Divi's Lab?

What is the Market Cap of Divi's Lab?

What are the key metrics to analyse Divi's Lab?

What is the trend of Divi's Lab share price?